| Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019 VN Giri, KE Knudsen, WK Kelly, HH Cheng, KA Cooney, MS Cookson, ... Journal of Clinical Oncology 38 (24), 2798-2811, 2020 | 234 | 2020 |
| An oncolytic virus expressing a T-cell engager simultaneously targets cancer and immunosuppressive stromal cells JD Freedman, MR Duffy, J Lei-Rossmann, A Muntzer, EM Scott, J Hagel, ... Cancer research 78 (24), 6852-6865, 2018 | 149 | 2018 |
| Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies JD Freedman, J Hagel, EM Scott, I Psallidas, A Gupta, L Spiers, P Miller, ... EMBO molecular medicine 9 (8), 1067-1087, 2017 | 133 | 2017 |
| Overcoming barriers in oncolytic virotherapy with HDAC inhibitors and immune checkpoint blockade A Marchini, EM Scott, J Rommelaere Viruses 8 (1), 9, 2016 | 126 | 2016 |
| Oncolytic parvoviruses: from basic virology to clinical applications A Marchini, S Bonifati, EM Scott, AL Angelova, J Rommelaere Virology journal 12, 1-16, 2015 | 126 | 2015 |
| Solid tumor immunotherapy with T cell engager‐armed oncolytic viruses EM Scott, MR Duffy, JD Freedman, KD Fisher, LW Seymour Macromolecular Bioscience 18 (1), 1700187, 2018 | 78 | 2018 |
| Bi-and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples EM Scott, EJ Jacobus, B Lyons, S Frost, JD Freedman, A Dyer, ... Journal for ImmunoTherapy of Cancer 7, 1-18, 2019 | 73 | 2019 |
| Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells A Dyer, B Schoeps, S Frost, P Jakeman, EM Scott, J Freedman, ... Cancer Research 79 (2), 331-345, 2019 | 45 | 2019 |
| Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy H Khalique, R Baugh, A Dyer, EM Scott, S Frost, S Larkin, ... Journal for immunotherapy of cancer 9 (4), 2021 | 40 | 2021 |
| Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference A Dyer, R Baugh, SL Chia, S Frost, Iris, EJ Jacobus, H Khalique, ... Cancer gene therapy 26 (3), 59-73, 2019 | 25 | 2019 |
| Use of liquid patient ascites fluids as a preclinical model for oncolytic virus activity EM Scott, S Frost, H Khalique, JD Freedman, LW Seymour, ... Oncolytic Viruses, 261-270, 2020 | 9 | 2020 |
| Targeting tumour-associated macrophages with locally-expressed T cell engagers E Scott University of Oxford, 2020 | | 2020 |
| Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference TD Pokrovska, EM Scott, WK Taverner, LW Seymour, J Lei | | 2018 |
| European Association for Veterinary Pharmacology and Therapeutics. Proceedings of the 6th International Congress Edinburgh, UK 7-11 August, 1994. P Lees, D Baggot, P Chantler, A Coulson, J Elliot, P Keen, A Kidd, ... | | 1994 |
